Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

Patients with metastatic breast cancer treated with epirubicin and docetaxel had a good response and maintained their quality of life.

A new vaccine using a porous scaffold boosts immunity and protects against the flu better than traditional methods.

Adding hormone therapy to radiation improves survival for high-risk prostate cancer recurrence but has side effects.

Deleting Smad4 and PTEN genes in mice causes rapid, invasive stomach cancer.

The document concludes that pregnancy and cancer share immune evasion tactics, but more research is needed before using checkpoint blockade immunotherapy in pregnant cancer patients to avoid harm to the placenta.

A cholesterol-free liposomal platform using protopanaxadiol effectively promotes hair growth and treats alopecia.

Polynucleotides HPT improves Asian skin tone, firmness, and glow safely.

Dupilumab helps children with alopecia areata regrow hair safely.

Photobiomodulation therapy effectively promotes hair regrowth and improves quality of life in alopecia areata without side effects.

Tofacitinib helped regrow hair in most adolescents with alopecia areata, but more research is needed.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Risankizumab effectively treats and maintains skin clearance in moderate-to-severe psoriasis.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Targeted cancer therapies often cause serious skin problems that need careful management.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Secukinumab and acitretin together may quickly and effectively treat severe generalized pustular psoriasis.

Ritlecitinib is approved in the USA and Japan for treating severe hair loss in people aged 12 and older.

Ritlecitinib shows promise in improving hair regrowth in adolescents with alopecia areata.

Both treatments for alopecia areata are equally effective and safe.

UT-018 speeds up wound healing and boosts hair growth in mice.

Deucravacitinib helped a man regrow hair and improve psoriasis.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

MVP treatment is effective and safe for recurrent breast cancer.

Docetaxel, a chemotherapy drug, was reported to cause psoriasis in a patient for the first time.

The document concludes that the development of certain tumors is influenced by genetic background and that a specific gene modification can lead to tumor regression and reduced growth.

Tumor proteins can both promote and suppress cancer, depending on the situation.

Tofacitinib may be an effective and safe treatment for hair loss in teenagers with alopecia areata.

Tofacitinib can cause skin eruptions similar to palmoplantar pustulosis.